Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
for Renal Cell Carcinoma (RCC)
44 locations incl. Phoenix
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05176483·Phase 1·Recruiting·Listed Jan 2022
Exelixis Clinical
Clinical research site in Rochester, Minnesota
Part of Exelixis Clinical
As of July 2026, 2 paid clinical trials are recruiting at Exelixis Clinical in Rochester, Minnesota. Active studies at this site cover conditions such as Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Urothelial Carcinoma (UC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Exelixis Clinical (2)
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
for Advanced Solid Tumor
13 locations incl. Jacksonville
Sponsor: Exelixis
Sex: All·Age: 18+
Code: NCT05932862·Phase 1·Recruiting·Listed Jul 2023
More research sites in Rochester
- Mayo Clinic (453 trials)
- Mayo Clinic in Rochester (406 trials)
- Mayo Clinic Rochester (73 trials)
- Mayo Clinic - Rochester (34 trials)
- Mayo Clinic Minnesota (29 trials)
- Mayo Clinic in Rochester, Minnesota (13 trials)
- Mayo Clinic, Rochester (10 trials)
- Mayo Clinic Cancer Center (7 trials)
- Mayo Clinic in Minnesota (6 trials)
- Clinical Trial Site (5 trials)
Explore more
Paid clinical trials in Rochester, MN · Minnesota clinical trials